About the organization
Basic details : Envision Pharma Group is a global medical affairs agency, driven by evidence and enabled by technology. We can provide professional medical writing support to researchers (patient and nonpatient authors) to ensure ethical, timely, and complete reporting of research.Making the world a healthier place as the leading global partner for life science Medical Affairs departments
Mission : Envision Pharma Group is a global medical affairs agency, driven by evidence and enabled by technology. We can provide professional medical writing support to researchers (patient and nonpatient authors) to ensure ethical, timely, and complete reporting of research.
Vision : Making the world a healthier place as the leading global partner for life science Medical Affairs departments
Organization primary focus : Ethical and meaningful involvement of patients in medical affairs (eg, planning, generating, sharing, using and evaluating evidence)
Badges earned
Address
Envision House, 5 North Street RH12 1XQ Horsham, United Kingdom
Contact us for
General partnerships
Organization main contact email
Karen.Woolley@EnvisionPharmaGroup.com
Phone number
+61427556330
Conditions
People
Professor Karen Woolley
Global Lead, Patient Partnerships, Envision Pharma Group
Initiatives
Patient involvement in preparing clinical research peer-reviewed publications or results summaries: A systematic review
Patient Engagement How-To Module for the creation of Plain Language Summaries for scientific publications
Resources
Envision PLS showcase: Safety and effectiveness of apremilast in people with plaque psoriasis
16 Apr 2018
Envision PLS showcase: Study of a new version of exenatide, a treatment for people with diabetes that is given using a mini-pump under the skin
16 Apr 2018
Envision PLS showcase: Study to compare two combination treatments in Chinese people with stomach cancer
16 Apr 2018
Plain Language Summaries (PLS) of Publications Toolkit
10 Jul 2019 Plain Language Summaries (PLS)
DIA 2019 Panel Discussion - Patient Engagement Quality Guidance Results and Learnings from Global Multistakeholder Pilots
10 Jul 2019 Learning and training
The Future of Combination Products in the EU What Can we Learn from Medicine Development & Delivery
10 Jul 2019 Other
Patient involvement in preparing clinical research peer-reviewed publications or results summaries: A systematic review
04 Nov 2019 Book
Working Group Updates 2020
11 Mar 2020 Framework/guidance